Melvyn Freeman, Michelle Funk, Soumitra Pathare et al.
1
Menschenkind, HVD, et al.
1
Mercedes M. Maicán V., Ángel Granado, Jesús Cedeño, et al.
1
Mesic, Anita
1
Mèdecines sans Frontières MSF
1
Médecins sans Frontières MSF
1
Michigan State University, USAID
1
Minh D Pham
1
Ministerio de Salud y Protección Social
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministery of Public Health, Thailand
1
Ministère de la Santé et de l’Action Sociale et Ministère de la Justice
1
Ministère de la Santé Publique et de la Population (MSPP) Haiti
1
Ministère de la Santé Publique, Republique Démocratique du Congo
1
Ministério da Saúde Direcção Nacional de Saúde Pública Programa Nacional de Controlo da Tuberculose
1
Ministério da Saúde, Brasil
1
Ministry of health
1
Ministry of Health & Family Welfare Government of the Peoples Republic of Bangladesh
1
Ministry of Health & Family Welfare, Goverment of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Government of India
1
Ministry of Health and Sanitation Sierra Leone
1
Ministry of Health and Social Welfare, India
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health and Social Welfare, Zimbabwe
1
Ministry of Health Ghana
1
Ministry of Health Jordan
1
Ministry of Health, Ethiopia
1
Ministry of Health, Kingdom of Cambodia
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health, Madagascar
1
Ministry of Health, Rwanda
1
Ministry of Health. The Goverment of the Kingdom of Swaziland
1
Ministry of Medical Services, Kenya
1
Ministry of Public Health & Sanitation
1
Misereor, Brot für die Welt, GPF
1
Montelongo, A.
1
MONWANOU Djohodo Inès
1
Morse S.
1
MSF Access Campaign
1
MSF Médecins sans Frontières
1
MSF South Africa and Lesotho
1
MSH, USAID
1
Murni I. K., T. Duke, S. Kinney et al.
1
Müller, Olaf
1
Mwangi, Annabel
1
Myanmar, Ministry of Health and Sports
1
N. B. Karkara
1
N. Chowdhary, S.Dimidji and V. Patel
1
N. Forda
1
N. González Méndez de Vigo, J. Karpenstein und F. Schmidt
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
NACO
1
Nana Twum Danso, Uta Lehmann, Jennifer Nyoni et al.
1
National Academy of Medical Sciences
1
National Agency for the Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Council
1
National AIDS Control Organisation (NACO)
1
National AIDS&STI Control Program Kenya
1
National Cancer Control Programme, India
1
National Centre for Disease Control (formerly National Institute of Communicable Diseases)
1
National Council on Disability Affairs (NCDA)
1
National COVID-19 Clinical Evidence Tasforce
1
National Department of Health South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Institute of Health
1
National Institute of Mental Health & Neurosciences, Bengaluru India
1
National Malaria Control Programme (NMCP) Communicable Disease Control Division Directorate General of Health Services Ministry of Health & Family Welfare Bangladesh
1
National Rural Health Mission
1
National Statistical Office Zomba, Malawi
1
NCDC
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nepal Public Health Foundation
1
Net Hope
1
Neuropsychiatric hospital, Aro, Abeokuta, Nigeria
1
Nicole Ritz, Folke Brinkmann, Cornelia Feiterna-Sperling. et al.
1
Norwegian Ministry of Foreign Affairs
1
Nwe Ni Myint et al.
1
O'Sullivan, B.
1
O. Ajose
1
O. Drouin
1
OEA (Más derechos para más gente)
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Olans R. N. , R. D. Olans, A. DeMaria Jr
1
Olney, Jack J.
1
Open Journal of Epidemiology
1
OPSIC
1
Organisation for Economic Co-operation and Development (OECD)
1
Organisation for the Prohibition of Chemical Weapons (OPCW)
1
Organisation Mondiale de la Sante
1
Organización Mundial de la Salud
1
Organização Mundial da Saúde (Américas)
1
Organização Pan-Americana da Saúde
1
Oxfam Deutschland e.V.
1
Oxford
1
Öztürk, H.
1
O’Sullivan BG., Chater AB, Bingham A., et al.
1
P. Booth
1
P. De Castro
1
P. J. Dodd
1
PAHO/World Health Organization
1
Pan African Medical Journal
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO, World Health Organization WHO
1
Papst Franziskus
1
Pathfinder International
1
Patrick Smith, T. Dalgleish and R. Meiser‐Stedman
1
Páez Silva, Gustavo Alejandro
1
Peace Corps
1
Peter Cooper, Robert Johnson, Haroon Saloojee et al.
1
Peter Stastny
1
Peyton, D.
1
Philippine Society for Microbiology and Infectious Diseases
1
Philippine Society for Microbiology and Infectious Diseases, Philippine College of Chest Physicians, Philippine Academy of Family Physicians
1
Phillipine Department of Health
1
Phillips, Tamsin K.
1
Phimemon, Rune N., Michael J. Mahande, and Habib O. Ramadhani
1
PMC
1
PMC (US National Library of Medicine National Institutes of Health)
1
Poe Poe Aung
1
Prince, M., and J. Jackson
1
Prof. AHM E. Hussain
1
Prof. Dr. P. Bendel
1
Programme National de lutte contre la Tuberculose (PNT) - Sénégal
1
Programme national de lutte contre la tuberculose - Sénégal
1
Public Health Foundation India
1
PubMed.gov
1
Queeramnesty Schweiz
1
R Wood, L-G. Bekker
1
R. Baggaley
1
R. Bucciardini
1
R. Coninx
1
R. Furth
1
R. Granich
1
R. Jahn
1
R. L’Herminez
1
R. Turner
1
R4V
1
Raftery A, Tudor C, True L, Navarro C
1
Rahman-Shepherd, A.
1
Rajan, S.
1
Ramanathan, K.
1
Rasmussen, D.J., Karsberg, S., Karstoft, K-I. & Elklit, A.
1
rbfhealth.org
1
ReAct Action on Antibiotic Resistance
1
refugio stuttgart e.v.
1
Regina Hiller
1
Regional Office for Africa
1
Regional refugee & resilience plan in response to the Syria crisis
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.more
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
The Guidelines on promotive and preventive mental health interventions for adolescents - Helping Adolescents thrive (HAT), provide evidence-informed recommendations on psychosocial interventions to promote mental health, prevent mental disorders, and reduce self-harm and other risk behaviours among ...adolescents.
The HAT Guidelines aims to inform policy development, service planning and the strengthening of health and education systems, and facilitate mainstreaming of adolescent mental health promotion and prevention strategies across sectors and delivery platforms.more
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control.... Sequencing data emanating from AMR surveillance may provide key information to guide the development of rapid diagnostic tools for better and more rapid characterization of AMR, and thus complement phenotypic methods. This document addresses the applications of WGS for AMR surveillance, including the benefits and limitations of current WGS technologiesmore
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.more
The purpose of this document is to provide guidance on the use of pooled sample testing strategy in coronavirus disease (COVID-19)
testing laboratories of the African Union Member States for scaling up SARS-CoV-2 nucleic acid testing capacity with the available resources. The current document descr...ibes the effect of factors such as the prevalence of COVID-19 in the population to be tested, the homogeneity of pools, and the sensitivity of the molecular test in optimal pool size determination. It also highlights the importance of monitoring the prevalence of COVID-19 in a population to be tested and proper validation of the test, to limit the potential for false-negative results. Validation studies to determine the optimal pool size by testing laboratories are recommended as the optimum approach. A safe, simple ‘two-stage pooling’ option has been indicated in this guidance to be used by laboratories until such validation can be achieved.more
he statistics in this report are from the Emergency Events Database (EM-DAT) maintained by the Centre for Research on the Epidemiology of Disasters (CRED) which records disasters which have killed ten or more people; affected 100 or more people; resulted in a declared state of emergency; or a call f...or international assistance.
In the period 2000 to 2019, there were 7,348 major recorded disaster events claiming 1.23 million lives, affecting 4.2 billion people (many on more than one occasion) resulting in approximately US$2.97 trillion in global economic losses.
This is a sharp increase over the previous twenty years. Between 1980 and 1999, 4,212 disasters were linked to natural hazards worldwide claiming approximately 1.19 million lives and affecting 3.25 billion people resulting in approximately US$1.63 trillion in economic losses.
Much of the difference is explained by a rise in climate-related disasters including extreme weather events: from 3,656 climate-related events (1980-1999) to 6,681 climate-related disasters in the period 2000-2019.more
Updated version – September 2020
The COVID-19 pandemic is affecting everyone. Globally, millions of people have been infected with the virus, while hundreds of thousands have lost their lives. In Moldova, the pandemic is placing an ever-increasing pressure on the health care and social protectio...n systems, causing major disruptions to economic processes and limitations to social life, deepening inequalities and proving how vulnerable we are.more
Addendum: 2020 mid-year COVID-19 resvision, summary of the reprioritisation & additional requirements in response to COVID-19
In June and July 2020, a mid-year revision of the 2020 South Sudan Regional Refugee Response Plan (RRRP) was undertaken as an inter-agency consultative process to discuss ...and document the reprioritization of activities and corresponding budgets for the rest of the year, taking into account the impacts of COVID-19 and other developments.more
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ...the release of waste into the environment. Climate resilient and environmentally sustainable health care facilities contribute to high quality of care and accessibility of services, and by helping reduce facility costs also ensure better affordability. They are, therefore, an important component of universal health coverage (UHC).more
Under the theme Equity at the Heart of Health, this Plan seeks to catalyze efforts in Member States to reduce inequities in health within and between countries and territories in order to improve health outcomes. The Plan identifies specific actions to tackle health inequality, including those recom...mended by the Commission on Equity and Health Inequalities in the Americas, with guidance from the High-level Commission for Universal Health. Four cross-cutting themes are central to this Plan’s approach to addressing the determinants of health: equity, gender, ethnicity, and human rightsmore
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of socioeconomic development . The Vision 2030 aims to transform Zambia into a prosperous middle-income country as articulated also in the 7th National De...velop-ment Plan (7NDP) and National Health Strategic Plan 2017 – 2021 (NHSP 2017-2020). However, this aspiration is threatened by the double burden of Communicable and Non-Communicable Diseas¬es. Zambia has been recording an increase in morbidity and mortality due to Non-Communicable Diseases (NCDs) such as cancers, diabetes, chronic respiratory and cardiovascular diseases. According to the 2016 WHO NCD country profiles, 29% of all deaths in Zambia are attributed to NCDs. This is unacceptably high, considering that most of these diseases can be reduced by modifying four main behavioural risk factors for NCDs which are tobacco use, harmful use of alcohol, unhealthy diets and physical inactivity.more
This report presents an assessment of the institutional readiness to detect, prevent and address health issues associated with ASGM and aims to provide an input to the Ministry of Health (MISAU) to define key priorities in the Public Health Strategy on ASGM. Based on the consultation of representati...ves of MISAU as well as various other ministries and stakeholder groups concerned with ASGM, the report assesses institutional capacity strengths and challenges in the public health sector and identifies key stakeholders relevant for the development and implementation of a public health strategy for the ASGM sector.more
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop...ia at least 31.3 billion birr (US$ 1.1 billion) per year, equivalent to 1.8% of the gross domestic product (GDP). Less than 15% of the costs are for health care.more
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report... on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019) presents a decade’s worth of data on drug efficacy and surveillance, as well as recommendations to monitor and protect the efficacy of malaria treatment in the decades to come.more